They are a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Our common stock is currently quoted on the electronic marketplace operated by OTC Markets Group, Inc. under the symbol "SENH", and, to date, has traded on a limited basis. On March 4, 2016, the last reported sale price of our common stock was $3.30. We have applied to list our common stock on the NYSE-MKT under the symbol "SENS."
Last Closing Price
March 18, 2016
Leerink Partners, Canaccord Genuity
To view the prospectus for Senseonics Holdings, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253